Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicenter randomized double-blind placebo-controlled trial of live attenuated varicella vaccine in healthy participants
CTR20223312Phase 3Active
- Sponsor
- Beijing Institute of Biological Products
- Start
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of varicella vaccine live in chickenpox, sponsored by Beijing Institute of Biological Products. Started Dec 2022; status: active.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20223312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223312.